Literature DB >> 7055901

Stability of frozen liquid control sera for assay of cholesterol in high-density lipoprotein.

P N Demacker, A G Hijmans, D F van Sommeren-Zondag, A P Jansen.   

Abstract

Liquid serum pools with low-, normal-, or above-normal concentration of high-density lipoprotein cholesterol were prepared by selection and dilution of sera having low lipoprotein content or by enrichment with concentrated high-density lipoprotein. Stability of the serum pools depended on storage conditions. On storage between -2 and -12 degrees C, the high-density lipoprotein cholesterol content decreased. At a constant temperature of -19 to -21 degrees C the concentrations remained stable for more than 18 months. The imprecision (CV) of the high-density lipoprotein cholesterol assay during this period as established with enzymic cholesterol analysis (Clin. Chem. 26: 1780-1786, 1980) of these serum pools was between 2.7 and 4.8% (n = 51). Serum pools prepared and stored as described are suitable for internal quality-control procedures. In external quality-control trials these sera may be superior to the commercially available lyophilized lipid control sera.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7055901

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  2 in total

1.  Influence of contraceptive pill and menstrual cycle on serum lipids and high-density lipoprotein cholesterol concentrations.

Authors:  P N Demacker; R W Schade; A F Stalenhoef; P M Stuyt; A van't Laar
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-24

2.  Serum samples that have been stored long-term (>10 years) can be used as a suitable data source for developing cardiovascular risk prediction models in large observational rheumatoid arthritis cohorts.

Authors:  Elke E A Arts; Calin D Popa; Jacqueline P Smith; Onno J Arntz; Fons A van de Loo; Rogier Donders; Anne Grete P Semb; George D Kitas; Piet L C M van Riel; Jaap Fransen
Journal:  Biomed Res Int       Date:  2014-09-11       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.